Document Classification

Section Type: RESULTS

Text: There was no difference between dexmedetomidine versus placebo groups in primary end points : change of somatosensory EPs at T1, latency : 0. 01 1. 3 (-0. 64, 0. 65) vs 0. 01 1. 3 (-0. 64, 0. 65), P = 0. 43 (-1. 24, 0. 45) ; amplitude : 0. 03 0. 14 (-0. 06, 0. 02) vs -0. 01 0. 13 (-0. 07, 0. 05), P = 0. 76 (-0. 074, 0. 1) ; motor EPs amplitude at T1 : 65. 1 194. 8 (-35, 165 ; n = 18) vs 109. 2 241. 4 (-24, 243 ; n = 16), P = 0. 57 (-113. 5, 241. 57) ; visual EPs at T1 (right eye), amplitude : 2. 3 3. 6 (-0. 4, 5. 1 ; n = 11) vs 0. 3 6. 0 (-3. 3, 3. 9 ; n = 16), P = 0. 38 (-6. 7, 2. 6) ; latency N1 : 2. 3 3. 6 (-0. 4, 5. 1) vs 0. 3 6. 0 (-3. 3, 3. 9), P = 0. 38 (-6. 7, 2. 6) ; latency P1 : -1. 6 13. 4 (-11. 9, 8. 7) vs -1. 4 8. 1 (-6. 3, 3. 5), P = 0. 97 (-9. 3, 9. 7) or secondary end points.